Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07124650

Sore Throat After Open Neck Elective Surgery

Effect of Hydrocortisone and Lidocaine on Endotracheal Tube for Sore Throat and Hoarseness After Thyroid/Parathyroid Surgery With Neuromonitoring: A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
764 (estimated)
Sponsor
Saint Petersburg State University, Russia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized clinical trial aims to evaluate the effectiveness of two medications-hydrocortisone ointment and lidocaine solution-applied to the endotracheal tube in reducing postoperative throat pain, hoarseness, and cough following thyroid or parathyroid surgery with neuromonitoring. A total of 764 adult patients undergoing elective neck surgery at Saint-Petersburg State University Hospital will be enrolled and randomly assigned to receive either a hydrocortisone-coated or lidocaine-coated endotracheal tube. Outcomes will be assessed upon awakening from anesthesia, at 24 hours, and again at 3 days postoperatively. The findings may contribute to improving postoperative comfort and recovery for patients undergoing similar surgical procedures.

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisone Acetate 1% OintmentEndotracheal tubes will be coated with 1% hydrocortisone acetate ointment prior to intubation. The ointment will be applied uniformly to the outer surface of the tube. This intervention aims to reduce postoperative throat inflammation and pain.
DRUGLidocaine hydrochloride 0,05% with chlorhexidineEndotracheal tubes will be treated with 0.05% lidocaine hydrochloride solution combined with chlorhexidine (Cathejell). The solution will be applied to the tube surface before intubation to provide local anesthesia and reduce postoperative throat discomfort.

Timeline

Start date
2025-09-15
Primary completion
2026-12-01
Completion
2027-05-01
First posted
2025-08-15
Last updated
2026-04-13

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT07124650. Inclusion in this directory is not an endorsement.